<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03983109</url>
  </required_header>
  <id_info>
    <org_study_id>EPS01</org_study_id>
    <nct_id>NCT03983109</nct_id>
  </id_info>
  <brief_title>EpiFaith Syringe for Epidural Space Detection</brief_title>
  <official_title>Identify the Epidural Space With EpiFaith Syringe in Air and Saline Based Procedures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Flat Medical Co., Ltd</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Flat Medical Co., Ltd</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study is to verify the efficacies of both air and saline based procedure
      of EpiFaith syringe for assisting the needle localization of the epidural space.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 23, 2019</start_date>
  <completion_date type="Anticipated">November 2019</completion_date>
  <primary_completion_date type="Anticipated">September 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Success of epidural localization</measure>
    <time_frame>30 minutes</time_frame>
    <description>Defined as the catheter can be inserted into epidural space successfully, no cold perception in the blocked dermatomes after the injection of anesthetic by cold sensation test, and no occurrence of inadvertent dural puncture.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The time to identify the epidural space</measure>
    <time_frame>30 minutes</time_frame>
    <description>Defined as the time of the successful localization from the first syringe attached to the Tuohy needle to the occurrence of LOR signal.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of the epidural space localization procedure</measure>
    <time_frame>30 minutes</time_frame>
    <description>Defined as the time from the puncture of skin to the successful insertion of the epidural catheter.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of attempts</measure>
    <time_frame>30 minutes</time_frame>
    <description>Defined as the insertion of the epidural catheter is unsuccessful or the perception of cold exists in the blocked dermatomes after the injection of anesthetic by cold sensation test.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The distance from the skin to the epidural space</measure>
    <time_frame>30 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of change insertion segment</measure>
    <time_frame>30 minutes</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Epidural Localization</condition>
  <arm_group>
    <arm_group_label>Detection by EpiFaith syringe with air</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Detection by EpiFaith syringe with saline</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EpiFaith loss of resistance detect syringe</intervention_name>
    <description>An EpiFaith syringe will be used to detect the loss of resistance and facilitate the needle localization.</description>
    <arm_group_label>Detection by EpiFaith syringe with air</arm_group_label>
    <arm_group_label>Detection by EpiFaith syringe with saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  20 years and older

          -  Surgery requiring epidural anesthesia or analgesia

          -  ASA Physical Status 1 to 3

        Exclusion Criteria:

          -  Bleeding and clotting disorders

               -  Platelet count &lt; 100,000 / mm3

               -  International normalized ratio (INR) &gt; 1.5

          -  History of peripheral neuropathy

          -  Neuromuscular or neuropsychiatric disease

          -  Marked spinal deformities or a history of spinal instrumentation

          -  Systemic infection

          -  Skin infection at the injection site

          -  Significant heart failure, e.g. New York Heart Association (NYHA) Functional
             Classification 3 or 4
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Chien-Kun Ting, MD</last_name>
    <phone>88628757549</phone>
    <phone_ext>386</phone_ext>
    <email>ckting2@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Taipei Veterans General Hospital</name>
      <address>
        <city>Taipei</city>
        <state>Please Select</state>
        <zip>11217</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Li Yu Lin</last_name>
      <phone>886970507710</phone>
      <email>liyulin0611@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>June 10, 2019</study_first_submitted>
  <study_first_submitted_qc>June 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 12, 2019</study_first_posted>
  <last_update_submitted>June 10, 2019</last_update_submitted>
  <last_update_submitted_qc>June 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 12, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>EpiFaith</keyword>
  <keyword>Epidural localization</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

